Cargando…
Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement
The dismal outcome of pleuropericardial extramedullary multiple myeloma (EMM) reflects both the selection of resistant disease and absence of useful drugs. Carfilzomib and dexamethasone should be explored in advanced EMM patients, even for bortezomib‐resistant patients, as may provide much longer ov...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538069/ https://www.ncbi.nlm.nih.gov/pubmed/28781837 http://dx.doi.org/10.1002/ccr3.1015 |
| _version_ | 1783254297419448320 |
|---|---|
| author | Español, Ignacio Romera, Marta Gutiérrez‐Meca, María Dolores García, Maria del Carmen Tejedor, Aurelia Martínez, Antonio Ibáñez, Jerónima De Arriba, Felipe Minguela, Alfredo Iturbe, Teodoro López, Maria Dolores |
| author_facet | Español, Ignacio Romera, Marta Gutiérrez‐Meca, María Dolores García, Maria del Carmen Tejedor, Aurelia Martínez, Antonio Ibáñez, Jerónima De Arriba, Felipe Minguela, Alfredo Iturbe, Teodoro López, Maria Dolores |
| author_sort | Español, Ignacio |
| collection | PubMed |
| description | The dismal outcome of pleuropericardial extramedullary multiple myeloma (EMM) reflects both the selection of resistant disease and absence of useful drugs. Carfilzomib and dexamethasone should be explored in advanced EMM patients, even for bortezomib‐resistant patients, as may provide much longer overall survival than previously reported treatments. |
| format | Online Article Text |
| id | pubmed-5538069 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55380692017-08-04 Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement Español, Ignacio Romera, Marta Gutiérrez‐Meca, María Dolores García, Maria del Carmen Tejedor, Aurelia Martínez, Antonio Ibáñez, Jerónima De Arriba, Felipe Minguela, Alfredo Iturbe, Teodoro López, Maria Dolores Clin Case Rep Case Reports The dismal outcome of pleuropericardial extramedullary multiple myeloma (EMM) reflects both the selection of resistant disease and absence of useful drugs. Carfilzomib and dexamethasone should be explored in advanced EMM patients, even for bortezomib‐resistant patients, as may provide much longer overall survival than previously reported treatments. John Wiley and Sons Inc. 2017-06-22 /pmc/articles/PMC5538069/ /pubmed/28781837 http://dx.doi.org/10.1002/ccr3.1015 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Case Reports Español, Ignacio Romera, Marta Gutiérrez‐Meca, María Dolores García, Maria del Carmen Tejedor, Aurelia Martínez, Antonio Ibáñez, Jerónima De Arriba, Felipe Minguela, Alfredo Iturbe, Teodoro López, Maria Dolores Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement |
| title | Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement |
| title_full | Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement |
| title_fullStr | Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement |
| title_full_unstemmed | Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement |
| title_short | Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement |
| title_sort | carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538069/ https://www.ncbi.nlm.nih.gov/pubmed/28781837 http://dx.doi.org/10.1002/ccr3.1015 |
| work_keys_str_mv | AT espanolignacio carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT romeramarta carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT gutierrezmecamariadolores carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT garciamariadelcarmen carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT tejedoraurelia carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT martinezantonio carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT ibanezjeronima carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT dearribafelipe carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT minguelaalfredo carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT iturbeteodoro carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement AT lopezmariadolores carfilzomibanddexamethasoneforextramedullarymyelomawithpleuropericardialinvolvement |